Table 1 Surveys of screening preference for colorectal cancer

Steine⁹

GI Patients 45–79 y

BE v C

Post hoc

Durdey¹⁰

GI Patients 19–88 y

BE v C

Post hoc

VanNess¹¹

GI Patients 20–84 y

BE v C

Post hoc

Elwood²⁰

Relatives of GI Patients 45–70 y

FS v C

RCT; Subjects offered FS or C and differential compliance measured

Dominitz¹²

VAOP 50–75 y

FS v C

Time trade off measure Least for FS.

Frew¹³

PCOP >25 y

FOBT v FS

Willingness to pay primary endpoint. Preference also collected.

Leard¹⁴

PCOP 50–75 y

FOBT, FS, BE, C

Post hoc 93% previously screened

Dolan¹⁷

PCOP >50 y

FOBT, FS, BE, C

DARCT

Pignone¹⁵

PCOP 50–75 y

FOBT v FS

DARCT

Pignone¹⁸

PCOP 50–75 y

FOBT v FS

4 levels of survey after varying quantities of information on colon cancer risk, conduct, test accuracy, cost.

Wolf¹⁶

PCOP >65 y

FOBT v FS

DARCT

Nelson

Non-patients 18–54 y

FOBT, FS, BE, C